HF 2096 requires health care providers to publicly disclose, in a single document updated annually, the prices for their 25 most common services using both standard medical codes and plain language descriptions. Hospitals must disclose prices for their 75 most common inpatient and 75 outpatient services (grouped by Medicare standards), updated quarterly, in the same accessible format. All disclosed prices must include a clear disclaimer stating they are estimates, not binding charges, and actual costs may vary based on individual circumstances. The law directs Iowa's health department to align these requirements with existing federal price transparency rules to avoid duplication. This bill directly affects all health care providers and hospitals in Iowa by mandating standardized, publicly available pricing for common services.
HF 2249 establishes new rules for vision benefit managers in Iowa, directly affecting optometrists and vision care providers who contract with these plans. The bill requires that reimbursement rates for covered vision services must be at least the Medicare physician fee schedule for those services, updated annually for inflation. It also mandates that the time frame for vision benefit managers to recover payments from providers (chargebacks) must match the time they have to pay providers, and prohibits managers from favoring providers based on discounts, volume, or brand. These provisions aim to create fairer payment practices and greater transparency in vision care billing.
HF 2142 limits Medicaid claim reviews by restricting post-payment reviews to claims paid within the last 12 months, unless fraud or misrepresentation is involved. It prohibits providers from being required to repay overpayments identified more than 12 months after claim payment or having those amounts offset against future reimbursements. The bill allows providers to resubmit claims identified as improper through reviews as claims adjustments. It does not apply to retroactive cost settlements or rate changes based on Medicaid/Medicare cost reports, directly affecting Medicaid providers like hospitals and clinics.
HF 61 requires health care providers to publicly list prices for their 25 most common services (with coding and plain-language descriptions) online, updated annually. Hospitals must list prices for 75 most common inpatient and 75 outpatient services (using Medicare grouping) online, updated quarterly. All disclosed prices must include a disclaimer stating they are estimates, not binding charges, and actual costs may vary. The bill directs Iowa's department to align these requirements with existing federal price transparency rules under the Affordable Care Act.
HF 58 requires Iowa health insurance plans to cover treatment for eating disorders, directly affecting patients with conditions like anorexia, bulimia, or binge eating disorder and their insurers. The bill mandates coverage for all services in a patient's treatment plan - including therapy, medications, hospitalization, and out-of-network care when local options are unavailable and medically necessary - without stricter copays or deductibles than for physical illnesses. It applies to most individual and group health plans starting January 1, 2026, excluding accident-only, dental, or Medicare supplement insurance. The Iowa Insurance Commissioner must create rules to enforce these requirements.
SF 87 requires most health insurance plans in Iowa to cover acupuncture services performed by licensed acupuncturists, starting January 1, 2026. The bill mandates that this coverage must be equally favorable as coverage for general physical illness, meaning out-of-pocket costs (like deductibles or copays) cannot be higher than for standard medical care. It applies to individual, group, and small group health insurance plans but excludes dental, vision, Medicare supplements, workers' compensation, and other specialized coverage. This law directly affects health insurance providers and policyholders by expanding covered services without increasing patient costs relative to conventional medical treatments.
SF 71 creates an annual 30-day open enrollment period for Iowa Medicare supplement policies, starting January 1, 2026, beginning on the applicant's birthday. It directly affects Iowans aged 65+ seeking individual policies, or those under 65 who qualify for Medicare due to disability, end-stage renal disease, or environmental hazard exposure. During this period, insurers cannot deny coverage, charge more based on health status, or exclude preexisting conditions. Applicants may switch to policies with the same or fewer benefits than their current coverage. The bill requires insurers to provide clear notice of this enrollment period to applicants.
HF 70 creates an annual 31-day open enrollment period for Medicare supplement insurance (Medigap) starting March 1 each year, beginning January 1, 2025. It directly affects individuals seeking Medicare supplement policies, including those under 65 who qualify for Medicare due to disability, end-stage renal disease, or environmental hazard exposure. During this period, insurers are prohibited from denying coverage, charging higher premiums based on health status, or excluding preexisting conditions for at least one policy they offer. Insurers must also provide clear notice of the enrollment period to applicants. The bill aims to simplify access to Medigap plans while protecting consumers from health-based discrimination.
SF 197 requires Iowa health insurance plans to cover prescription drugs for advanced (stage 4) cancer and related symptoms without forcing patients to try cheaper alternatives first. It applies to most health insurance policies (like employer plans and HMOs) starting January 1, 2026, but excludes accident-only, Medicare supplement, and workers' compensation plans. Coverage must be provided for FDA-approved drugs that are medically necessary for metastatic cancer and supported by scientific evidence. This directly affects insurers selling plans in Iowa and benefits patients with advanced cancer needing these specific treatments.
SF 209 requires most health insurance plans in Iowa to cap out-of-pocket costs for prescription insulin at $25 per prescription (for up to a 31-day supply). It directly affects people with diabetes who have insurance covering insulin, limiting their cost-sharing for four types: rapid-acting, short-acting, intermediate-acting, and long-acting insulin. The bill sets this $25 maximum for plans issued or renewed after January 1, 2026, while excluding certain insurance types like Medicare supplements. Insurers may lower costs below $25 but cannot exceed this cap for covered insulin drugs.
